Ignite Creation Date:
2024-05-06 @ 3:32 PM
Last Modification Date:
2024-10-26 @ 1:51 PM
Study NCT ID:
NCT04666454
Status:
RECRUITING
Last Update Posted:
2024-01-03
First Post:
2020-12-07
Brief Title:
BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart Takotsubo Syndrome
Sponsor:
Vastra Gotaland Region
Organization:
Vastra Gotaland Region
Study Overview
Official Title:
BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart Takotsubo Syndrome A Multinational Multicentre Registry-based Open-label Randomized Controlled Trial
Status:
RECRUITING
Status Verified Date:
2023-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to document an optimized pharmacologic treatment for patients with Takotsubo Syndrome There is currently no published documentation in a large number of patients The study is a Randomized Registry Clinical Trial and in total 1000 patients registered in SWEDEHEART will be included
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None